A quick analysis of Inovio Pharmaceuticals‘ (NASDAQ: INO) stock performance history shows plenty of twists and turns — from the company’s early biomedical days to its recent advances in developing a Zika virus vaccine. But this chart shows the story hasn’t been great for investors.
Data sources: 10-K filing, Yahoo! Finance, YCharts.
Here’s a brief overview of what has happened with Inovio Pharmaceuticals’ stock over the last couple of decades.